Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study-Reference-Cited by-同舟云学术

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study

Published:2023-12 Issue: Volume:Volume 16 Page:3561-3574
ISSN:1178-7015
Container-title:Clinical, Cosmetic and Investigational Dermatology
language:en
Short-container-title:CCID

Author:

Russo Filomena^ORCID,Galluzzo Marco,Stingeni Luca^ORCID,Persechino Severino,Zichichi Leonardo,Conti Andrea,Giofrè Claudia,Dini Valentina^ORCID,Vispi Martina,Atzori Laura,Cattaneo Angelo,Parodi Aurora,Bardazzi Federico,Stinco Giuseppe,Dapavo Paolo,Girolomoni Giampiero^ORCID,Musumeci Maria Letizia,Papini Manuela^ORCID,Venturini Marina^ORCID,Dastoli Stefano,Di Nuzzo Sergio,Fargnoli Maria Concetta^ORCID,Pagnanelli Gianluca,Bernardini Nicoletta^ORCID,Gambini Daniele,Malagoli Piergiorgio,Mazzatenta Carlo^ORCID,Peris Ketty,Zalaudek Iris,Fabbrocini Gabriella,Loconsole Francesco,Vassallo Camilla,Pietroleonardo Lucia,Prignano Francesca,Franchi Chiara,Offidani Anna Maria,Bonifati Claudio,Di Lernia Vito,Gigante Giovanni,Bartezaghi Marta,Franchi Matteo,Ursoleo Paola,Aloisi Elisabetta

Publisher

Informa UK Limited

Subject

Dermatology

Reference28 articles.

1. Psoriasis pathophysiology: current concepts of pathogenesis

2. The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings

3. Immunology of Psoriasis

4. HLA-Cw6-Positive and HLA-Cw6-Negative Patients with Psoriasis Vulgaris have Distinct Clinical Features

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study;Journal of Clinical Medicine;2024-06-30